Aspen Pharmacare Holdings Limited announced the board of directors confirm the following appointments, with effect from 7 March 2024: Ms. Neo Dongwana as an independent non-executive director and member of Aspen's Audit & Risk Committee; and Mr. Reginald Haman (prescribed officer and member of Aspen's Social and Ethics Committee) as an executive director. Ms. Dongwana currently serves as a non-executive director on the Nedbank Group Limited board. She previously served as a non-executive director and chairperson of Barloworld Limited and as a non-executive director on the boards of, inter alia, Mpact Limited and AVI Limited.

Ms. Dongwana is a Chartered Accountant (SA) by profession, with an MCom (Accounting) (University of Witwaterstrand) and BCom Hons (Financial Analysis and Portfolio Management) (University of Cape Town). She is also a member of the African Women Chartered Accountants. Mr. Haman joined Aspen in May 2020 as the Group Chief Corporate Services Officer and is a member of Aspen's Group Executive Committee.

His responsibilities comprise leading Aspen's portfolio of Group enablement, governance and shared service functions (including technology, people, strategic business processes, ESG and information). Mr. Haman has extensive experience as a business executive and non-executive director in various industries, including mining and financial services. He holds an MBA (Gordon Institute of Business Science) and other relevant business qualifications.